UCB (UCBJF) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UCBJF UCB SA UCBJF
92 GF Score
Price $273.25
GF Value $262.16
Valuation Fairly Valued
View Full Analysis

What is UCB Float Percentage Of Total Shares Outstanding?

UCB UCBJF -2.27% 92 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 19, 2026. GuruFocus rates UCBJF with a GF Score™ of 92/100 and a GF Value™ of $262.16 (Fairly Valued).

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, UCB's float shares is 0.00 Mil. UCB's total shares outstanding is 190.36 Mil. UCB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, UCB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, UCB's Institutional Ownership is 0.01%.

UCBJF
92GF Score
UCB SA UCBJF
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UCB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

UCB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/190.36
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
UCB (UCBJF) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 19, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on UCB and its competitors.
Is UCB's Float Percentage Of Total Shares Outstanding too high?
UCB's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, UCB has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UCB's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
UCB's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on UCB and its competitors. UCB's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCB stock overvalued right now?
Based on GuruFocus' analysis, UCB (UCBJF) is currently considered Fairly Valued. The stock's GF Value™ is $262.16, compared to a current price of $273.25 — trading 4.2% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. UCB's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For UCB (UCBJF), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UCB (UCBJF) Overvalued in 2026?

Based on GuruFocus' analysis, UCB stock appears to be overvalued. The current stock price of $273.25 is trading 4.2% above its estimated GF Value™ of $262.16. GuruFocus considers UCB to be Fairly Valued.

Key valuation signals for UCBJF:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: $262.16 vs. price of $273.25 (4.2% above fair value)
  • GF Score™: 92/100

No single metric tells the full story. See the UCBJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UCB Business Description

Address Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome), and Kygevvi (rare mitochondrial disease).
92GF Score

Get the complete analysis for UCBJF

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$273.25
Price
$262.16
GF Value